Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma-Reference-Cited by-同舟云学术

Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma

Published:2024-05 Issue:5 Volume:57 Page:1105-1123.e8
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

De Leo Alessandra,Ugolini Alessio,Yu Xiaoqing,Scirocchi Fabio,Scocozza Delia,Peixoto Barbara,Pace Angelica,D’Angelo Luca,Liu James K.C.,Etame Arnold B.,Rughetti Aurelia,Nuti Marianna,Santoro Antonio,Vogelbaum Michael A.,Conejo-Garcia Jose R.,Rodriguez Paulo C.,Veglia Filippo

Funder

American Cancer Society

Ben and Catherine Ivy Foundation

National Cancer Institute

National Institute of Neurological Disorders and Stroke

Publisher

Elsevier BV

Reference85 articles.

1. Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration;Ott;JCI Insight,2020

2. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target;Abdelfattah;Nat. Commun.,2022

3. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma;Goswami;Nat. Med.,2020

4. A review of glioblastoma immunotherapy;Medikonda;J. Neurooncol.,2021

5. Brain immunology and immunotherapy in brain tumours;Sampson;Nat. Rev. Cancer,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of biomarkers associated with histone lactylation modification in spinal cord injury;2024-09-05

2. The important role of lactylation in regulating DNA damage repair and tumor chemotherapy resistance;Drug Resistance Updates;2024-09

3. Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer;2024-08-08

4. Global profiling of protein lactylation in microglia in experimental high-altitude cerebral edema;Cell Communication and Signaling;2024-07-25

5. Vaccine-based immunotherapy and related preclinical models for glioma;Trends in Molecular Medicine;2024-07